A memo reportedly circulating among White House officials this week targets Amodei's perceived connections to effective ...
CRISPR Therapeutics AG remains a long-term Buy, anchored by Casgevy's success and management’s execution in ex vivo gene ...
President Donald Trump's allies are seeking to make Anthropic CEO Dario Amodei the face of AI "doomerism," opening a new ...
Anthropic and OpenEvidence are deploying free AI clinical decision support across 100 low- and middle-income countries, building on 42 million US ...
OpenAI and Anthropic quietly killed a deal to probe each other's AI models after it reached the contracts stage, and the ...
Anthropic used roughly 950 Claude AI agents to analyze more than 200,000 enzymes and uncover a previously uncharacterized biological system.
Anthropic's IPO path is fueling a powerful AI safety donor network ahead of the 2026 midterms, with $20M in advocacy spending ...
Accenture’s latest AI push comes as the stock remains about 32% lower this year and faces questions over consulting demand.
Google, OpenAI and Anthropic are pushing forward with a plan to create a new AI safety-focused standards body on their own, without government oversight, in hopes of launching it by the end of the ...
Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.
Anthropic’s Chief Economist Peter B. McCrory said Wednesday that his team is exploring whether the artificial intelligence company can steer its technology toward augmenting workers rather than ...
US artificial intelligence startup Anthropic yesterday unveiled the first discovery from its molecular biology lab, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results